Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Osteogenic Therapy in Established Osteoporosis
NCT00018447Phase 2Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Nov 1998
- Modality
- Recombinant Proteins and Enzymes, Inorganic Nanoparticles, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ZT-034 and fluoride in postmenopausal osteoporosis (3 arms), sponsored by United States Department of Veterans Affairs. Primary endpoint: Bone Mineral Density of the Spine at 3 years. Started Nov 1998; status: completed.
02
Drugs
ZT-034fluoride
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00018447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00018447.